The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party Web sites. We encourage you to read the privacy policy of every Web site you visit. Click "Continue" to proceed or "Return" to return to LillyMedical.com.
Please select the therapeutic area you would like to see more about.
Menu closed
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Men's Health Journal Publications
This page includes links to Lilly sponsored clinical trials that have been published in peer reviewed journals over the last 3 years. The list of publications below is limited to products that have been approved for use and may contain information about doses, uses, formulations and populations different from product labeling. Please refer to the product’s Full Prescribing Information in the provided link.
If you have questions about a Lilly study not listed below or would like to request an electronic copy of one of the journal publications on this page, please Contact Lilly services below for further assistance.
Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia Published Date: November 1, 2017 Publication Link
Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia Published Date: November 1, 2017 Publication Link
Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease Published Date: February 23, 2017 Publication Link
Evaluation of the long-term safety and effectiveness of tadalafil once daily in Chinese men with erectile dysfunction: interim results of a multicenter, randomized, open-label trial Published Date: July 10, 2018 Publication Link
Safety and efficacy of the combination of once‐daily tadalafil and alpha‐1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo‐controlled, cross‐over study Published Date: May 30, 2017 Publication Link
Safety and effectiveness of tadalafil in patients with pulmonary arterial hypertension: Japanese post-marketing surveillance data Published Date: March 21, 2017 Publication Link
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.